10
Participants
Start Date
January 16, 2023
Primary Completion Date
January 1, 2025
Study Completion Date
September 1, 2025
Aspirin
Run-in phase during one week with daily aspirin intake at 8 AM; visit 1: blood sampling at H24 and H2; intermediate phase (two weeks): daily aspirin intake at 8 PM; visit 2: blood sampling at H12; then daily intake of aspirin at the time preferred by the patient and study end visit 2 weeks after visit 2
RECRUITING
Toulouse Hospital, Toulouse
University Hospital, Toulouse
OTHER